What Is Checked For Diabetes?

Share on facebook

Check Ups For Your Diabetes

Children and parents will be taught how to look after their diabetes by specialist nurses in the paediatric department. This is a very specialist subject , not covered in detail here. type 2 various education programs Adults also need to be taught about their diabetes. General advice includes information about a healthy diet, and advice as to how to reduce weight if overweight. Ask for an appointment with a dietician if you are having problems controlling your diabetes, or need to lose weight but can't. The education courses opposite are invaluable. Adults need to learn how to test their own blood sugar ; everyone should do this unless they are too old or poorly. A chiropodist should advise you how to look after your feet, and an optometrist expert in detecting retinopathy should check your eyes (and do this every year as below). Foot infections can spread rapidly. Great care is needed , especially if you have neuropathy (reduced feeling in your toes). examine feet every day for cuts or anything unusual. Avoid direct heat and hot water bottles (you may have reduced feeling). Check shoes fit well, and check inside of shoes every day for sharp objects. Do not use sharp instruments. Continue reading >>

Share on facebook

Popular Questions

  1. sugarnotrequire

    After renewing my BC/BS Federal Employee Program health insurance in October 2016, BC/BS's letter dated 1/17/17 has informed me that its elevating the Lantus to a Tier 3: Non-Preferred Drug category. As such, BC/BS will significantly increase my co-pay for Lantus going forward. BC/BS states in its letter "As a courtesy in 2017, you can receive up to four 90-day supply prescriptions of Basaglar at no charge if you change to Basaglar. Alternatively, if you change from Lantus to the insulin Levemir - also a preferred tier 2 insulin - you will be eligible for up to four 90-day supply prescriptions of Levemir at no charge. Both Levemir and Basaglar are long acting insulins, but Basaglar is known as a follow on biologic of Lantus. This means it is biologically similar to Lantus and does not have any significant clinical differences (BC/BS is stating this to me, the consumer, like I went to class with my pharmacist ) . Both Basaglar and Levemir will require a new prescription from your doctor." Now to add salt to the wound, I last saw my endo in November 2016 who is affiliated with a metropolitan teaching hospital and she never brought this up while renewing my new prescriptions! So are there any long term Type 1s out there who have used Lantus and then switched to either the Basaglar and/or Levemir insulins? If so, please let me know what your experience was like with Basaglar or Levemir and why you chosed one over the other. Thank you!
    Type 1, Dx 1980
    Celiac Disease, Dx 2011

  2. libperr

    I have always taken Levemir as my long acting; I can't take Lantus because I have cysts on my liver. Another thing to know is that there is a savings card for Novolog which can also be used on Levemir, since they are made by the same company.

  3. mollythed

    Donna, Basaglar is a fairly new new product. It was only approved by the FDA in December 2015. That was too late in the calendar year for insurers to make changes in their formularies for 2016.
    Once the patent for Lantus expired, there has been a scramble by the pharmaceutical giants and some legal maneuvering to come up with similar products that they can market to insurance companies at more competitive prices. I was sort of surprised when I got my 2017 update from my BCBS of MN insurance company to see that Lantus was still covered in the same tier for me.
    Basaglar is so similar to Lantus that it was allowed to skip clinical trials for its efficacy (effectiveness) and rely on the trials used to get Lantus approve. Still it is just enough different to avoid being called a generic glargine insulin, so pharmacists can't just substitute it for Lantus at a lower price. That's the part about being a follow on product instead of a generic and needing a new prescription. For Eli Lilly and Boehringer Ingelheim, who market Basaglar, it gives them a change to break into the long acting insulin market that has been dominated by Sanofi-Aventis and NovoNordisk (Levemir).
    I would expect that you wouldn't need more than a phone call to your doctor's office to get your prescription changed, and that the the change would be a lot like that swapping back and forth between Novolog and Humalog that some of us have to put up with. I'd be surprised if your doctor preferred one over the other. By next year, for all we know, prices may be more competitive and people using long acting insulin may have access to Lantus again at the same price.

  4. -> Continue reading
read more close

Related Articles

Popular Articles

More in diabetes